Weight Research / 09.09.2024

Tirzepatide is an innovative medication recently making waves in the treatment of type 2 diabetes and obesity. Known by its brand names, Mounjaro and Zepbound, this medication is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. While its efficacy in managing blood glucose levels and supporting weight loss is noteworthy, it’s crucial for patients and healthcare providers to fully understand the potential side effects associated with tirzepatide. This article delves into the detailed aspects of tirzepatide side effects, providing key insights for those considering this medication.

What is Tirzepatide?

Tirzepatide belongs to a new class of medications designed to manage blood sugar in adults with type 2 diabetes. It works by mimicking the action of two incretin hormones—GIP and GLP-1—which help regulate insulin secretion, slow down gastric emptying, and reduce appetite. These combined effects make tirzepatide particularly effective for controlling blood sugar levels and promoting weight loss, making it a dual-action treatment option. (more…)
Author Interviews, Weight Research / 16.10.2023

MedicalResearch.com Interview with: John A. Batsis, MD, FACP, AGSF, FGSA, FTOS Associate Professor Division of Geriatric Medicine, School of Medicine Department of Nutrition, The Gillings School of Global Public Health Chapel Hill, NC 27599 MedicalResearch.com: What is the background for this study? Response: The rationale for this study is that there has been a flurry of new medications that have been approved for the treatment of obesity in older adults. MedicalResearch.com: What are the main findings? Response: Our main findings are that the rates of weight loss promoting (WLP) medications (those that are prescribed for weight loss or have evidence that lead to significant weight loss) are rising and that there is a robust association between the rates of limitations (physical limitations, instrumental activities of daily living, and basic activities of daily living) and the use of weight loss promoting medications. In those persons with obesity, older adults taking weight loss promoting have higher rates of being of physical limitations. (more…)